BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16757578)

  • 1. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
    Hsu YH; Chung MW; Li TK
    Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of RNA polymerase modifications on transcription-induced negative supercoiling and associated R-loop formation.
    Broccoli S; Rallu F; Sanscartier P; Cerritelli SM; Crouch RJ; Drolet M
    Mol Microbiol; 2004 Jun; 52(6):1769-79. PubMed ID: 15186424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Cozzarelli NR
    Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities.
    Fisher LM; Pan XS
    Methods Mol Med; 2008; 142():11-23. PubMed ID: 18437302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chirality sensing by Escherichia coli topoisomerase IV and the mechanism of type II topoisomerases.
    Stone MD; Bryant Z; Crisona NJ; Smith SB; Vologodskii A; Bustamante C; Cozzarelli NR
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8654-9. PubMed ID: 12857958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides based on CcdB protein as novel inhibitors of bacterial topoisomerases.
    Trovatti E; Cotrim CA; Garrido SS; Barros RS; Marchetto R
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6161-4. PubMed ID: 18938079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
    Alt S; Mitchenall LA; Maxwell A; Heide L
    J Antimicrob Chemother; 2011 Sep; 66(9):2061-9. PubMed ID: 21693461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedimentation analysis of bacterial nucleoid structure.
    Drlica K; Chen CR; Kayman S
    Methods Mol Biol; 1999; 94():87-98. PubMed ID: 12844865
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
    Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
    J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase IV is a target of quinolones in Escherichia coli.
    Khodursky AB; Zechiedrich EL; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11801-5. PubMed ID: 8524852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.
    Aubry A; Fisher LM; Jarlier V; Cambau E
    Biochem Biophys Res Commun; 2006 Sep; 348(1):158-65. PubMed ID: 16876125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
    Hardy CD; Cozzarelli NR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):941-7. PubMed ID: 12604525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site.
    Leo E; Gould KA; Pan XS; Capranico G; Sanderson MR; Palumbo M; Fisher LM
    J Biol Chem; 2005 Apr; 280(14):14252-63. PubMed ID: 15659402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of three topoisomerases that regulate DNA supercoiling levels in Chlamydia.
    Orillard E; Tan M
    Mol Microbiol; 2016 Feb; 99(3):484-96. PubMed ID: 26447825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping E. coli Topoisomerase IV Binding and Activity Sites.
    El Sayyed H; Espéli O
    Methods Mol Biol; 2018; 1703():87-94. PubMed ID: 29177735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.
    Chatterji M; Sengupta S; Nagaraja V
    Arch Microbiol; 2003 Nov; 180(5):339-46. PubMed ID: 13680098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.
    Aedo S; Tse-Dinh YC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5458-64. PubMed ID: 22869559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylylation of Gyrase and Topo IV by FicT Toxins Disrupts Bacterial DNA Topology.
    Harms A; Stanger FV; Scheu PD; de Jong IG; Goepfert A; Glatter T; Gerdes K; Schirmer T; Dehio C
    Cell Rep; 2015 Sep; 12(9):1497-507. PubMed ID: 26299961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations reducing replication from R-loops suppress the defects of growth, chromosome segregation and DNA supercoiling in cells lacking topoisomerase I and RNase HI activity.
    Usongo V; Martel M; Balleydier A; Drolet M
    DNA Repair (Amst); 2016 Apr; 40():1-17. PubMed ID: 26947024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.